EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

138 hedge funds and large institutions have $1.18B invested in EyePoint Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 15 closing their positions.

Holders
138
Holders Change
+40
Holders Change %
+40.82%
% of All Funds
2.02%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.07%
New
56
Increased
40
Reduced
30
Closed
15
Calls
$60.4M
Puts
$35.2M
Net Calls
+$25.2M
Net Calls Change
+$32.4M

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$140M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$103M
3
Morgan Stanley
3
Morgan Stanley
New York
$61M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$36M
5
Ameriprise
5
Ameriprise
Minnesota
$35.5M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
EWM
2
Essex Woodlands Management
Texas
$54M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$570K
4
HighTower Advisors
4
HighTower Advisors
Illinois
$693K
5
GTC
5
Ghost Tree Capital
New York
$3.81M
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
151
Qube Research & Technologies (QRT)
United Kingdom
– -$80.7K -10,106 Closed
UIA
152
Ulland Investment Advisors
Minnesota
– -$4K -500 Closed
MIM
153
Macroview Investment Management
Maryland
– -$2.65K -331 Closed
3 4 5 6
7